VACBF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Nykode Therapeutics ASA

Watchlist Manager

Watchlist

Price: 0.3542 USD Market Closed

Market Cap: $115.7m

	Nykode Therapeutics ASA OTC:VACBF	NO
P	Paul Hartmann AG SWB:PHH2	DE
E	Equity Commonwealth F:HP5A	US
C	CLP Holdings Ltd XMUN:CLP	HK
K	Konica Minolta Inc XMUN:KPI1	JP
	K-Bro Linen Inc F:74R	CA
O	Oriola Oyj XBER:O5O	FI
	Northern Shield Resources Inc F:N9SA	CA
G	Gensource Potash Corp XMUN:UGN	CA
T	TrueCar Inc F:5TC	US
	RemeGen Co Ltd OTC:REGMF	CN
	Ambra SA F:1W7	PL
	Aztec Minerals Corp F:AZ3	CA
P	Premium Snacks Nordic AB F:N3K	SE
	EcoSynthetix Inc F:0Y8	CA

Profitability Summary

Nykode Therapeutics ASA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-645%

Low Net Margin

Negative 3Y Average Net Margin

-410%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-894%

Negative ROE

-11%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-159%

ROIC is Increasing

-577% > -56%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.